Angiodysplasia cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Nikita Singh (talk | contribs) No edit summary |
Nikita Singh (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Angiodysplasia}} | {{Angiodysplasia}} | ||
{{CMG}} {{AE}} {{NKS}} | |||
{{PleaseHelp}} | |||
Currently, endoscopy is the diagnostic modality of choice, and argon plasma coagulation is the most cost-effective endoscopic therapy for the bleeding lesions. | |||
==References== | ==References== |
Revision as of 23:03, 3 September 2021
Angiodysplasia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Angiodysplasia cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Angiodysplasia cost-effectiveness of therapy |
Risk calculators and risk factors for Angiodysplasia cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nikita Singh, M.D.[2]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Currently, endoscopy is the diagnostic modality of choice, and argon plasma coagulation is the most cost-effective endoscopic therapy for the bleeding lesions.